symbol,statement_type,period_end,line_item,value
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Treasury Shares Number,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,111881150.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,111881150.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,393500000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,10351150000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,14423990000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,7831140000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,10351150000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,178140000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,14208630000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,14300460000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,14686700000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,478070000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,14208630000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,13984870000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,223760000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,223760000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,1526770000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,559220000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,336340000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,209170000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,117340000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,91830000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,13710000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,967550000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,85280000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Taxes Liabilities,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,184330000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,60800000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,123530000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,213680000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Payables,217930000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,45920000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,172010000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,16213470000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,7414780000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,30880000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,101920000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,99840000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,99840000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,3857480000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,523080000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,3334400000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,3146320000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,3146320000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,216910000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,2929410000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Properties,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,8798690000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,110710000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Inventory,1573050000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,1030000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,1153990000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,5959910000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,5017660000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,942250000.0
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
ADVENZYMES.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Treasury Shares Number,0.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,111824075.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,111824075.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,473080000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,9405470000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,13492400000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,7031140000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,9405470000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,221960000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,13241280000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,13310880000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,13710800000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,469520000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,13241280000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,30310000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,10794910000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,821310000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,223650000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,223650000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,1643830000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,580260000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,8860000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,343240000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,228160000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,158560000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,69600000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,8860000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,1063570000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,135910000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Taxes Liabilities,
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,244920000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,63400000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,181520000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,196750000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Payables,524610000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,274020000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,1590000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,91410000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,157590000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,15354630000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,7259930000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,300000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,80230000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,142820000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,1710000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,60000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,1650000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,3835810000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,582860000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,3252950000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,3072660000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-1880840000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,4953500000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,307370000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,2765280000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,2665830000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,1399320000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,580980000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,8094710000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,17260000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,2260000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,111040000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Inventory,1484550000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,357870000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,363410000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,763270000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,14200000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,985680000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-12360000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,998040000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,5479720000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,4342210000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,1137510000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,717480000.0
ADVENZYMES.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,420030000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Treasury Shares Number,
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,111824075.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,111824075.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,334990000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,8533380000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,12483080000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,6434900000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,8533380000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,202600000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,12350690000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,12428680000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,12841710000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,491020000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,12350690000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,12127040000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,10022770000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,821310000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,223650000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,223650000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,1376760000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,601100000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,5060000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,372270000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,223770000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,145780000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,77990000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,5060000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,775660000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,105220000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Taxes Liabilities,
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,111220000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,56820000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,54400000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,37190000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Payables,550850000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,292630000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,1170000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,14840000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,242210000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,14218470000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,7007910000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,850000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,62410000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,113420000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,1700000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,50000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,1650000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,3817310000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,608780000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,3208530000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,2888220000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-1620480000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,4508700000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,156090000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,2732130000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,2500370000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,1280500000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,571740000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,7210560000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,9680000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,5920000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,98160000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Inventory,1239900000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,286530000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,325840000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,627530000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,10680000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,1003410000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-15470000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,1018880000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,4842810000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,3878610000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,964200000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,363680000.0
ADVENZYMES.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,600520000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Treasury Shares Number,
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,111800675.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,111800675.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,347300000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,7262240000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,10995330000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,5399320000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,7262240000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,237900000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,10885930000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,10967230000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,11403860000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,517930000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,10885930000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,6400000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,9072970000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,813550000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,223600000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,223600000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,1272230000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,668010000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,10680000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,392500000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,264830000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,183530000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,81300000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,10680000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,604220000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,97750000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Taxes Liabilities,
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,82470000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,54370000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,28100000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,38220000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Payables,414200000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,232160000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,1080000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,1990000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,178970000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,12676090000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,6672550000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,840000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,81280000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,74200000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,700000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,50000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,650000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,3623690000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,663060000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,2960630000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,2718080000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-1374110000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,4092190000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,96280000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,2621800000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,2341960000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,1123940000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,530010000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,6003540000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,4730000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,44770000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,98970000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Inventory,1209200000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,347250000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,303540000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,558410000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,26410000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,882060000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-8480000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,890540000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,3737400000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,1063850000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,2673550000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,819940000.0
ADVENZYMES.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,1853610000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Treasury Shares Number,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,7977310000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,789560000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,-10000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,13560000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Taxes Liabilities,5390000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Payables,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,236730000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,920000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,67660000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,650000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-1107070000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,2164880000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,873860000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,530010000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,3650000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,95240000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,232520000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,212240000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,494050000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-7280000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,870020000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,738720000.0
ADVENZYMES.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,1180470000.0
